Immune evasive mechanisms contributing to persistent Leishmania donovani infection
- PMID: 20087685
- DOI: 10.1007/s12026-009-8135-4
Immune evasive mechanisms contributing to persistent Leishmania donovani infection
Abstract
The protozoan parasite Leishmania donovani, a causative agent of visceral leishmaniasis, has evolved several strategies to interfere with the immune system and establish persistent infections that are potentially lethal. In this article, we discuss two mechanisms of immune evasion adopted by the parasite: the induction of immune suppressive IL-10 responses and the generation of poor and functionally impaired CD8(+) T-cell responses.
Similar articles
-
The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.J Interferon Cytokine Res. 2000 Jan;20(1):63-77. doi: 10.1089/107999000312748. J Interferon Cytokine Res. 2000. PMID: 10670653
-
IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection.PLoS Pathog. 2015 Jun 5;11(6):e1004938. doi: 10.1371/journal.ppat.1004938. eCollection 2015 Jun. PLoS Pathog. 2015. PMID: 26046638 Free PMC article.
-
Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.PLoS Negl Trop Dis. 2012;6(8):e1798. doi: 10.1371/journal.pntd.0001798. Epub 2012 Aug 21. PLoS Negl Trop Dis. 2012. PMID: 22928057 Free PMC article.
-
Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives.Curr Opin Microbiol. 2012 Aug;15(4):476-85. doi: 10.1016/j.mib.2012.05.002. Epub 2012 Jun 13. Curr Opin Microbiol. 2012. PMID: 22698479 Review.
-
Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.Trends Parasitol. 2004 Nov;20(11):524-30. doi: 10.1016/j.pt.2004.08.009. Trends Parasitol. 2004. PMID: 15471704 Review.
Cited by
-
Optimal control and cost-effective analysis of malaria/visceral leishmaniasis co-infection.PLoS One. 2017 Feb 6;12(2):e0171102. doi: 10.1371/journal.pone.0171102. eCollection 2017. PLoS One. 2017. PMID: 28166308 Free PMC article.
-
Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype.PLoS Negl Trop Dis. 2015 Feb 24;9(2):e0003543. doi: 10.1371/journal.pntd.0003543. eCollection 2015 Feb. PLoS Negl Trop Dis. 2015. PMID: 25710789 Free PMC article.
-
Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites.Parasitol Res. 2012 Mar;110(3):1277-85. doi: 10.1007/s00436-011-2628-5. Epub 2011 Sep 14. Parasitol Res. 2012. PMID: 21915627
-
Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice.Vaccines (Basel). 2020 Mar 23;8(1):141. doi: 10.3390/vaccines8010141. Vaccines (Basel). 2020. PMID: 32210040 Free PMC article.
-
Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Front Immunol. 2014 Jun 13;5:272. doi: 10.3389/fimmu.2014.00272. eCollection 2014. Front Immunol. 2014. PMID: 24982655 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials